L. Tokgözoğlu
Surgery · 2007–2022
A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Surgery — 135 citations into it
- Endocrinology, Diabetes and Metabolism — 89 citations into it
Whom L. Tokgözoğlu trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Børge G. Nordestgaard (in Surgery)
Papers from L. Tokgözoğlu's perspective
Ordered by how strongly the researchers L. Tokgözoğlu trusts endorse each paper. Same corpus, a different order for every researcher.
- Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. (Journal of the American Medical Association (JAMA))
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans (Nature Genetics)
- Safety of anacetrapib in patients with or at high risk for coronary heart disease. (New England Journal of Medicine)
- Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. (Journal of the American College of Cardiology)
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management (European Heart Journal)
- Newly identified loci that influence lipid concentrations and risk of coronary artery disease (Nature Genetics)
- Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association (Circulation)
- Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (New England Journal of Medicine)
- Burden of valvular heart diseases: a population-based study. (The Lancet)
Their papers
- Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement (2022) — 1,097 citations
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society (2021) — 742 citations
- Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry (2019) — 760 citations
- Atherosclerosis (2019) — 2,081 citations
- EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries (2016) — 932 citations
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (2015) — 1,260 citations
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management (2011) — 1,241 citations
- Lipoprotein(a) as a cardiovascular risk factor: current status (2010) — 1,754 citations
- European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invit (2007) — 756 citations